MedPath

Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery

Phase 4
Completed
Conditions
Opioid Use
Interventions
Drug: Saline
Registration Number
NCT03044808
Lead Sponsor
Odense University Hospital
Brief Summary

Single center double blind randomised controlled trial. 60 subjects. Giving lidocaine IV or saline to patients due to robot assisted colorectal surgery. Primary outcome is cumulative morphine consumption at 24 hours.

Detailed Description

Prospective double blind randomised controlled trial. The investigators are giving lidocaine IV or saline to 60 patients undergoing robot assisted colorectal surgery. Blinding and randomization is done by the hospital pharmacy. Both groups get otherwise the same treatment and a IV PCA (patient controlled administration) morphine pump for objectivisation of opioid consumption. Other outcome measures are NRS (numerical rating score) pain score, PONV (postoperative nausea and vomiting), use of antiemetics and opioid consumption up to 72 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • all patients due to robotic laparoscopic colorectal surgery, > 18years of age, danish speaking
Exclusion Criteria
  • allergy to lidocain or amid local analgetics, atrioventricular blok, liver- and/or kidney failure, chronic use of opioids or NSAIDS, pregnancy, breastfeeding women, treatment with betablockers, porphyria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlSalinePatients get the same amount in ml and duration as if it was the experimental arm. Only in this arm it is isotonic saline instead.
LidocainLidocainePatient gets the experimental treatment with IV lidocain 0,5mg/ml, 1,5mg/kg bolus before induction of anesthesia, after that infusion of 1,5mg/kg/h is started and continued until 2 hours after end of surgery.
Primary Outcome Measures
NameTimeMethod
Reduction in morphine consumptionover the first 24 hours

PCA morphine added to PN (per necessitae) morphine, cumulated

Secondary Outcome Measures
NameTimeMethod
Use of antiemetics postoperativefirst 72 hours
PONVup to 72 hours

Postoperative nausea and vomiting - patient is asked

Reduction in morphine consumptionover the first 72hours

PCA morphine added to PN morphine, cumulated

Time to bowel functionfirst 72 hours

time to flatus or defecation or function of bowel stoma

time to dischargeup to 72 hours

Trial Locations

Locations (1)

Odense Universitetshospital

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath